Linked infacebooktwitteryoutube
MGI

MGI Partners with Human Cell Atlas to Advance Global Human Cell Mapping

NHS Wales

NHS Wales and Illumina Expand Partnership to Advance Genomic Cancer Detection and Personalized Medicine

Genomics England

Unlocking Genomic Potential for Rare Cancers: Cancer52 and Genomics England’s Collaborative Approach

Tempus AI

Tempus AI Launches Immune Profile Score to Enhance Precision in Immunotherapy for Advanced Cancer Patients

Guidelines

Key Resources and Organizations for Precision Medicine Guidelines

MedGenome

MedGenome Strengthens Leadership Team to Drive North American Expansion in Precision Medicine

NCCN

NCCN Expands Clinical Practice Guidelines for High-Risk Genetic Cancer Assessment

MicrobioTx

MicrobioTx Launches Gut Function Test (GFT) for Easy, Affordable Gut Health Profiling

Roche

Roche to Present Over 40 Abstracts on Blood Disorders at 66th ASH Annual Meeting, Showcasing Advances in Lymphoma Treatments

Hamad Medical Corporation

Hamad Medical Corporation Hosts 3rd Precision Medicine Conference on AI and Genomics Integration

Caris Life Sciences

Caris Life Sciences Receives FDA Approval for Groundbreaking MI Cancer Seek™ Diagnostic Assay for Precision Oncology

Alzheimer's disease

IWG Proposes New Clinical-Biological Definition for Diagnosing Alzheimer’s Disease

Inify Laboratories

Inify Laboratories and Karolinska Institutet's ProMort Team Partner to Transform Prostate Cancer Diagnostics with AI

Oxford Nanopore

UK Government and Oxford Nanopore Forge Partnership to Advance Genomics in the NHS, Enhancing Patient Care and Biosecurity

HuidaGene Therapeutics

HuidaGene Therapeutics Gains FDA Clearance for First CRISPR/Cas13 RNA-Editing Therapy HG202 to Treat Macular Degeneration